GoodRx bets on work­ing with phar­ma­cies as pre­scrip­tion-drug re­im­burse­ment pres­sure grows

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

When GoodRx made its pub­lic de­but in 2020, the dig­i­tal health com­pa­ny built its busi­ness by work­ing with phar­ma­cy ben­e­fit man­agers, get­ting paid when cus­tomers used a PBM coupon to pay phar­ma­cies in cash rather than through in­sur­ance. But over the last year, it’s been shift­ing its mod­el to work more close­ly with phar­ma­cies, ne­go­ti­at­ing deals with them di­rect­ly rather than re­ly­ing sole­ly on PBMs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER